FORMULATION AND CHARACTERISATION OF RISEDRONATE SODIUM SUBLINGUAL SPRAY
DOI:
https://doi.org/10.22159/ijcpr.2024v16i6.6004Keywords:
Risedronate sodium, Sublingual spray, Ex-vivo permeation study, Face centred composite designAbstract
Objective: To formulate a propellant-free sublingual spray of Risedronate sodium, addressing issues of gastrointestinal side effects associated with current oral formulations and improving patient compliance.
Methods: Initially, a fractional factorial design was used to screen variables, followed by a face-centered central composite design for optimization. Formulation batches were characterized by spray pattern, spray angle, leak test, prime test, drug delivery uniformity, drug content per spray, and ex-vivo permeation study.
Results: The optimized batch O1 exhibited an ovality ratio of 1.1, a spray angle of 640, and a drug permeation percentage of 4. In vivo absorption analysis revealed that the relative bioavailability of optimized batch O1 was 2.27 times higher than that of the plain drug solution. Compatibility of the product pack with excipients and the drug was confirmed through stability studies of batch O1.
Conclusion: The study concluded that Risedronate sodium sublingual spray presents a promising alternative to oral administration, potentially reducing gastrointestinal side effects and enhancing patient compliance.
Downloads
References
Strampel W, Emkey R, Civitelli R. Safety considerations with bisphosphonates for the treatment of osteoporosis. Drug Saf. 2007;30(9):755-63. doi: 10.2165/00002018-200730090-00003, PMID 17722968.
Barbosa JS, Almeida Paz FA, Braga SS. Bisphosphonates old friends of bones and new trends in clinics. J Med Chem. 2021 Feb 11;64(3):1260-82. doi: 10.1021/acs.jmedchem.0c01292, PMID 33522236.
Brown JP, Davison KS, Olszynski WP, Beattie KA, Adachi JD. A critical review of brand and generic alendronate for the treatment of osteoporosis. Springer Plus. 2013 Dec;2(1):550. doi: 10.1186/2193-1801-2-550.
Compston JE. The therapeutic use of bisphosphonates. BMJ. 1994 Sep 17;309(6956):711-5. doi: 10.1136/bmj.309.6956.711, PMID 7950525.
Ebetino FH, Hogan AM, Sun S, Tsoumpra MK, Duan X, Triffitt JT. The relationship between the chemistry and biological activity of the bisphosphonates. Bone. 2011;49(1):20-33. doi: 10.1016/j.bone.2011.03.774, PMID 21497677.
LI N, Zhang G, Zhang X, Liu Y, Kong Y, Wang M. A rapid floating natural polysaccharide gel raft with double effect for the treatment of gastroesophageal reflux disease. Int J Biol Macromol. 2024;261(1):129667. doi: 10.1016/j.ijbiomac.2024.129667, PMID 38272401.
Chauhan B, Shimpi S, Mahadik K, Paradkar A. Preparation and evaluation of floating risedronate sodium gelucire 39/01 matrices. Acta Pharm. 2004 Sep;54(3):205-14. PMID 15610617.
Dissette V, Bozzi P, Bignozzi CA, Dalpiaz A, Ferraro L, Beggiato S. Particulate adducts based on sodium risedronate and titanium dioxide for the bioavailability enhancement of oral administered bisphosphonates. Eur J Pharm Sci. 2010;41(2):328-36. doi: 10.1016/j.ejps.2010.06.020, PMID 20619342.
Jung IW, Han HK. Effective mucoadhesive liposomal delivery system for risedronate: preparation and in vitro/in vivo characterization. Int J Nanomedicine. 2014 May;9:2299-306. doi: 10.2147/IJN.S61181, PMID 24872692.
Pathak K, Raghuvanshi S. Oral bioavailability: issues and solutions via nanoformulations. Clin Pharmacokinet. 2015 Apr;54(4):325-57. doi: 10.1007/s40262-015-0242-x, PMID 25666353.
Wang Z, Chow MS. Overview and appraisal of the current concept and technologies for improvement of sublingual drug delivery. Ther Deliv. 2014 Jul;5(7):807-16. doi: 10.4155/tde.14.50, PMID 25287387.
Talevi A, Bellera CL. Drug metabolism. In: The adme encyclopedia: a comprehensive guide on biopharmacy and pharmacokinetics; 2022. p. 362-8.
Sivaraman A, Banga AK. Formulation and evaluation of sublingual delivery of piroxicam using thermosensitive polymer with an inverted franz diffusion cell. J Pharm Pharmacol. 2016 Jan 25;68(1):26-35. doi: 10.1111/jphp.12493, PMID 26714423.
Madibone MN, Gaikwad SS, Nikam VK. A review on sublingual route is the most promising choice in an emergency. ACCTRA. 2018 Oct 15;5(3):200-15. doi: 10.2174/2213476X05666180413160420.
LU W, Luo H, WU Y, Zhu Z, Wang H. Preparation and characterization of a metered dose transdermal spray for testosterone. Acta Pharmaceutica Sinica B. 2013 Dec;3(6):392-9. doi: 10.1016/j.apsb.2013.10.003.
Paradkar M, Thakkar V, Soni T, Gandhi T, Gohel M. Formulation and evaluation of clotrimazole transdermal spray. Drug Dev Ind Pharm. 2015 Oct 3;41(10):1718-25. doi: 10.3109/03639045.2014.1002408, PMID 25579237.
Patel D, Kumar P, Thakkar HP. Lopinavir metered-dose transdermal spray through microporated skin: permeation enhancement to achieve therapeutic needs. J Drug Deliv Sci Technol. 2015 Oct;29:173-80. doi: 10.1016/j.jddst.2015.07.004.
LI N, Zhang G, Zhang X, Liu Y, Kong Y, Wang M. A rapid floating natural polysaccharide gel raft with double effect for the treatment of gastroesophageal reflux disease. Int J Biol Macromol. 2024;261(1):129667. doi: 10.1016/j.ijbiomac.2024.129667, PMID 38272401.
Cordeiro MM, Salvador A, Moreno MJ. Calculation of permeability coefficients from solute equilibration dynamics: an assessment of various methods. Membranes. 2022 Feb 23;12(3):254. doi: 10.3390/membranes12030254, PMID 35323728.
Gyanewali S, Kesharwani P, Sheikh A, Ahmad FJ, Trivedi R, Talegaonkar S. Formulation development and in vitro-in vivo assessment of protransfersomal gel of anti-resorptive drug in osteoporosis treatment. Int J Pharm. 2021 Oct 25;608:121060. doi: 10.1016/j.ijpharm.2021.121060, PMID 34500057.
Jia HJ, LI W, Zhao K. Determination of risedronate in rat plasma samples by ion-pair high-performance liquid chromatography with UV detector. Anal Chim Acta. 2006 Mar;562(2):171-5. doi: 10.1016/j.aca.2006.01.077.
Gonzalez Gonzalez O, Ramirez IO, Ramirez BI, O Connell P, Ballesteros MP, Torrado JJ. Drug stability: ICH versus accelerated predictive stability studies. Pharmaceutics. 2022;14(11):2324. doi: 10.3390/pharmaceutics14112324, PMID 36365143.
Chokshi A, Vangara K, Chilampalli S, Narayanan E, Potta T. Development of sublingual spray formulation containing ondansetron hydrochloride dihydrate. J Drug Deliv Sci Technol. 2019;53:101160. doi: 10.1016/j.jddst.2019.101160.
Mazzinelli E, Favuzzi I, Arcovito A, Castagnola R, Fratocchi G, Mordente A. Oral mucosa models to evaluate drug permeability. Pharmaceutics. 2023;15(5):1559. doi: 10.3390/pharmaceutics15051559, PMID 37242801.
Smith D, Artursson P, Avdeef A, DI L, Ecker GF, Faller B. Passive lipoidal diffusion and carrier mediated cell uptake are both important mechanisms of membrane permeation in drug disposition. Mol Pharm. 2014;11(6):1727-38. doi: 10.1021/mp400713v, PMID 24724562.
Lam JK, Cheung CC, Chow MY, Harrop E, Lapwood S, Barclay SI. Transmucosal drug administration as an alternative route in palliative and end-of-life care during the COVID-19 pandemic. Adv Drug Deliv Rev. 2020 Nov 1;160:234-43. doi: 10.1016/j.addr.2020.10.018, PMID 33137363.
Patel VF, Liu F, Brown MB. Advances in oral transmucosal drug delivery. J Control Release. 2011 Jul;153(2):106-16. doi: 10.1016/j.jconrel.2011.01.027, PMID 21300115.
Cui N, Dai CY, Mao X, LV X, GU Y, Lee ES. Poloxamer based scaffolds for tissue engineering applications: a review. Gels. 2022;8(6):360. doi: 10.3390/gels8060360, PMID 35735704.
Carrer V, Alonso C, Pont M, Zanuy M, Cordoba M, Espinosa S. Effect of propylene glycol on the skin penetration of drugs. Arch Dermatol Res. 2020;312(5):337-52. doi: 10.1007/s00403-019-02017-5, PMID 31786711.
Guo C, Doub WH. The influence of actuation parameters on in vitro testing of nasal spray products. J Pharm Sci. 2006 Sep;95(9):2029-40. doi: 10.1002/jps.20678, PMID 16865693.
Saifi Z, Shafi S, Ralli T, Jain S, Vohora D, Mir SR. Enhancing osteoporosis treatment through targeted nanoparticle delivery of risedronate: in vivo evaluation and bioavailability enhancement. Pharmaceutics. 2023 Sep 18;15(9):2339. doi: 10.3390/pharmaceutics15092339, PMID 37765307.
Published
How to Cite
Issue
Section
Copyright (c) 2024 VATSAL NAVAPARIYA, THOSAR MILIND M
This work is licensed under a Creative Commons Attribution 4.0 International License.
